NCT04332653 2026-03-09NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsNeoImmuneTechPhase 1/2 Completed215 enrolled 30 charts
NCT07407933 2026-02-12A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1/2 Not yet recruiting118 enrolled
NCT06494241 2026-01-30Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyAstraZenecaActive not recruiting1,000 enrolled
NCT03899792 2026-01-06LIBRETTO-121Eli Lilly and CompanyPhase 1/2 Active not recruiting36 enrolled 13 charts 2 FDA